ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer
NCT00325351
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Ovarian Neoplasms
Interventions
DRUG:
Sagopilone (ZK 219477) + carboplatin
Sponsor
Bayer